Prevalence of Bone Demineralization in Patients with Autoimmune Hepatitis: Influence of Clinical and Demographic Factors

Age (years) 58.1 8.2 48.3 13.4 0.02 Age of onset (years) 48.7 9.3 37.6 15.8 0.02 Duration (months) 64 (28.5-199.5) 61 (12-208) 0.77 BMI (kg/mt) 26.4 4.5 23.6 2.6 0.04 Average dose (HCE per mt) 12.6 (11.4-14.7) 12.6 (9.7-15.2) 0.54 Cumulative dose (gm) 42.5 (18.5-130.5) 49.2 (12.2-88.5) 0.92 25 (OH) D3 (ng/ml) 16.0 9.9 18.6 9.7 0.47 DHEAS (mmol/1) 0.47 (0.19-1.07) 0.74 (0.50-1.07) 0.15 Lumbar Z-score -0.15 0.99 -0.64 1.05 0.19 Total hip Z-score -0.41 0.78 -0.72 0.94 0.33